Published in J Exp Med on March 01, 1968
Ultrastructure of the human complement component, Clq (negative staining-glutamine synthetase-biologically active Clq). Proc Natl Acad Sci U S A (1972) 2.32
Electron microscopic studies of mouse immunoglobulin M; structure and reconstitution following reduction. Immunology (1970) 1.48
Studies on the reduction of a human 19S immunoglobulin M. Biochem J (1969) 1.41
Electron-microscopic evidence for reactions of axial filaments of Leptospira with IgM and IgG antibodies. Bull World Health Organ (1970) 1.17
Electron microscope study of surface immunoglobulin-bearing human tonsil cells. J Exp Med (1972) 1.12
Ultrastructure of papain and pepsin digestion fragments of human IgM globulins. J Exp Med (1969) 1.08
The ultrastructure of human thyroglobulin. J Exp Med (1968) 1.02
Tetrameric immune macroglobulins in three orders of bony fishes. Proc Natl Acad Sci U S A (1971) 1.00
The significance of erythrocyte antigen site density. I. Hemagglutination. J Clin Invest (1970) 0.99
Further studies on the ultrastructure of dimeric IgA of human origin. J Exp Med (1971) 0.88
Observations on the reactions between D-positive red cells and ( 125 I)IgM anti-D molecules and subunits. Immunology (1971) 0.86
Spontaneous re-aggregation of IgM subunits and restoration of antibody activity after reduction and alkylation of rabbit anti-Forssman antibody. Immunology (1969) 0.85
Thymus immunoglobulin receptors. Ontogenic development, response to antigenic stimulation and their possible role in the regulation of "aggressive" immune reactions. Immunology (1974) 0.80
The significance of erythrocyte antigen site density. II. Hemolysis. J Clin Invest (1971) 0.77
CHARACTERIZATION OF A HUMAN MACROGLOBULIN. I. THE MOLECULAR WEIGHT OF ITS SUBUNIT. J Biol Chem (1965) 4.37
Characterization of a human macroglobulin. II. Distribution of the disulfide bonds. J Biol Chem (1965) 3.64
Two types of gamma-globulin differing in carbohydrate content. Proc Soc Exp Biol Med (1956) 3.49
Number of binding sites of rabbit macroglobulin antibody and its subunits. Immunochemistry (1965) 2.16
Polypeptide chain structure of rabbit immunoglobulins. II. gamma-M-immunoglobulin. Biochemistry (1966) 1.84
Dissociation, reaggregation, and subunit structure studies of some human gamma-M-globulins. J Biol Chem (1967) 1.64
Papain fragmentation of the subunits of human macroglobulin. J Immunol (1967) 1.29
[A new method for the determination of cholesterol linked to serum alpha-lipoproteins and beta-lipoproteins]. Clin Chim Acta (1958) 1.11
Ultrastructure of gamma-M immunoglobulin and alpha macroglobulin: electron-microscopic study. Science (1967) 1.05
The morphologic characteristics of 19S antibody. J Immunol (1967) 1.04
Examination of virus-gamma-M antibody complexes by electron microscopy. I. Configuration of gamma-M antibodies and mode of attachment to antigen. Virology (1967) 0.93
Characterization of a human macroglobulin. IV. Studies of its conformation by fluorescence polarization. J Biol Chem (1966) 0.93
[Structure of human gamma-macroglobulins]. C R Acad Sci Hebd Seances Acad Sci D (1965) 0.89
Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol (1998) 10.94
Cell-free formation of protease-resistant prion protein. Nature (1994) 6.07
Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay. Antimicrob Agents Chemother (1990) 4.51
Affinity labeling of a phosphorylcholine binding mouse myeloma protein. Biochemistry (1972) 4.26
Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus. Virology (1983) 4.16
Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens. Virology (1981) 3.61
Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J Virol (1997) 3.44
Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature (1985) 3.38
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy. J Virol (1996) 3.21
Host genetic control of recovery from Friend leukemia virus-induced splenomegaly: mapping of a gene within the major histocompatability complex. J Exp Med (1974) 2.89
Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV: mapping of the effects to different regions of the viral genome. Cell (1986) 2.69
p24 antigen capture assay for quantification of human immunodeficiency virus using readily available inexpensive reagents. Methods (1997) 2.65
Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc Natl Acad Sci U S A (1995) 2.58
Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology (1995) 2.55
Characterization of scrapie infection in mouse neuroblastoma cells. J Gen Virol (1987) 2.54
Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. J Virol (1994) 2.51
Different murine cell lines manifest unique patterns of interference to superinfection by murine leukemia viruses. Virology (1985) 2.44
Prion protein and the transmissible spongiform encephalopathies. Trends Cell Biol (1997) 2.39
Scrapie infectivity found in resistant species. Nature (1998) 2.28
Immunity to retroviral infection: the Friend virus model. Proc Natl Acad Sci U S A (1997) 2.28
Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol (1994) 2.21
Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol (1989) 2.08
T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant. Science (1986) 2.06
Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting. J Virol Methods (1991) 2.01
Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein. EMBO J (2001) 1.95
Aleutian disease of mink: the antibody response of sapphire and pastel mink to Aleutian disease virus. J Immunol (1975) 1.95
Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex. Proc Natl Acad Sci U S A (1979) 1.95
Specificiy of lymphocyte-mediated cytotoxicity induced by in vitro antibody-coated target cells. Cell Immunol (1972) 1.93
Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen. J Virol (2000) 1.93
Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. J Virol (1988) 1.92
Molecular cloning and complete sequence of prion protein cDNA from mouse brain infected with the scrapie agent. Proc Natl Acad Sci U S A (1986) 1.92
Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity. J Exp Med (1976) 1.90
A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells. J Virol (1995) 1.87
Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol (1994) 1.85
Mutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidine. J Virol (1991) 1.79
Neuron-specific expression of a hamster prion protein minigene in transgenic mice induces susceptibility to hamster scrapie agent. Neuron (1995) 1.71
Studies on the role of the host immune response in recovery from Friend virus leukemia. I. Antiviral and antileukemia cell antibodies. J Exp Med (1976) 1.69
Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors. J Virol (1996) 1.68
Rfv-1 and Rfv-2, two H-2-associated genes that influence recovery from Friend leukemia virus-induced splenomegaly. J Immunol (1978) 1.66
Effect of murine host genotype on MCF virus expression, latency, and leukemia cell type of leukemias induced by Friend murine leukemia helper virus. Virology (1983) 1.62
Complete nucleotide sequence of Friend murine leukemia virus, strain FB29. Nucleic Acids Res (1991) 1.61
Respiratory syncytial virus. An outbreak of acute respiratory illnesses in a home for infants. Acta Paediatr Scand (1966) 1.60
Role of the host immune response in selection of equine infectious anemia virus variants. J Virol (1987) 1.56
Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice. J Virol (1992) 1.55
Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J Virol (1998) 1.52
V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1. J Virol (1999) 1.49
Purification and ultrastructure of Aleutian disease virus of mink. Nature (1975) 1.47
Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma. J Immunol Methods (1981) 1.46
Different H-2 subregions influence immunization against retrovirus and immunosuppression. Nature (1987) 1.43
Characterization of Ia8 antigen, thy-1.2 antigen, complement receptors, and virus production in a group of murine virus-induced leukemia cell lines. J Immunol (1976) 1.41
Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia. J Immunol (1983) 1.38
Treatment of HIV tissue culture infection with monoclonal antibody-ricin A chain conjugates. J Immunol (1989) 1.38
Antibody-induced modulation of Friend virus cell surface antigens decreases virus production by persistent erythroleukemia cells: influence of the Rfv-3 gene. Proc Natl Acad Sci U S A (1979) 1.38
Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J (1997) 1.36
Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. J Biol Chem (1998) 1.35
Sequences in the U5-gag-pol region influence early and late pathogenic effects of Friend and Moloney murine leukemia viruses. J Virol (1990) 1.34
Passage of undegraded dietary antigen into the blood of healthy adults. Quantification, estimation of size distribution, and relation of uptake to levels of specific antibodies. Scand J Immunol (1985) 1.34
Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene. J Virol (1992) 1.33
Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness. Proc Natl Acad Sci U S A (1995) 1.33
Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence. Curr Top Microbiol Immunol (1995) 1.29
H-2D control of recovery from Friend virus leukemia: H-2D region influences the kinetics of the T lymphocyte response to Friend virus. J Exp Med (1983) 1.28
Detection of prion protein mRNA in normal and scrapie-infected tissues and cell lines. J Gen Virol (1988) 1.28
In vivo and in vitro antibacterial activity of conglutinin, a mammalian plasma lectin. Scand J Immunol (1990) 1.28
Change in host cell tropism associated with in vitro replication of equine infectious anemia virus. J Virol (1989) 1.28
Detection and quantitation of immune complexes with a rapid polyethylene glycol precipitation complement consumption method (PEG-CC). Methods Enzymol (1981) 1.26
Pseudotyping of dual-tropic recombinant viruses generated by infection of mice with different ecotropic murine leukemia viruses. Virology (1985) 1.25
Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells. J Virol (1990) 1.24
Leukemia induction by a new strain of Friend mink cell focus-inducing virus: synergistic effect of Friend ecotropic murine leukemia virus. J Virol (1984) 1.19
Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. J Virol (1995) 1.18
Characterization of a neurologic disease induced by a polytropic murine retrovirus: evidence for differential targeting of ecotropic and polytropic viruses in the brain. J Virol (1995) 1.18
Monoclonal antibodies against Aleutian disease virus distinguish virus strains and differentiate sites of virus replication from sites of viral antigen sequestration. J Virol (1986) 1.18
Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence. J Virol (1999) 1.16
Murine leukemia virus infectious centers are dependent on the rate of virus production by infected cells. Virology (1978) 1.16
Influence of the murine MHC (H-2) on Friend leukemia virus-induced immunosuppression. J Exp Med (1986) 1.15
A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP. J Biol Chem (1995) 1.15
The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes. J Virol (1998) 1.15
Immunoprotective determinants in friend murine leukemia virus envelope protein. Virology (1998) 1.14
Formation and dissociation of virus-antibody complexes with special reference to the neutralization process. Prog Med Virol (1968) 1.14
Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus. J Virol (1991) 1.13
Persistence of infectious Friend virus in spleens of mice after spontaneous recovery from virus-induced erythroleukemia. J Virol (1979) 1.13
Cloning of a gene whose expression is increased in scrapie and in senile plaques in human brain. Science (1985) 1.13
N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro. J Biol Chem (2001) 1.12
Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen. Identification of class II loci of the H-2 as immune response genes. J Exp Med (1988) 1.11
Transmissible spongiform encephalopathies and prion protein interconversions. Adv Virus Res (2001) 1.11
Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update. Mol Biotechnol (1999) 1.10
Fine mapping of the friend retrovirus resistance gene, Rfv3, on mouse chromosome 15. J Virol (1999) 1.10
Structural aspects of Congo red as an inhibitor of protease-resistant prion protein formation. J Neurochem (1998) 1.09
Two pregnancy-associated serum proteins with pregnancy-specific beta1-glycoprotein determinants. Am J Obstet Gynecol (1978) 1.09
Ultrastructure of papain and pepsin digestion fragments of human IgM globulins. J Exp Med (1969) 1.08
CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes. J Immunol (1994) 1.07
Host genes conferring resistance to a central nervous system disease induced by a polytropic recombinant Friend murine retrovirus. J Virol (1990) 1.07
Ultrastructure of human C1q protein. Nat New Biol (1972) 1.06
Passage of undegraded dietary antigen into the blood of healthy adults. Further characterization of the kinetics of uptake and the size distribution of the antigen. Scand J Immunol (1986) 1.06
Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera. Clin Exp Immunol (1983) 1.06
Neurologic disease induced by polytropic murine retroviruses: neurovirulence determined by efficiency of spread to microglial cells. J Virol (1997) 1.06